Weight Management

Obesity Obesity Treatments Weight Loss Drugs Medications Weight Loss Medications Obesity Treatment Weight Loss Programs Weight Loss Weight-Loss Drugs Weight Loss Treatments

9 ARTICLES

last wk.

AstraZeneca H1 Revenue Jumps 11% as It Pledges $50 Billion U.S. Expansion

Robust double-digit profit growth spurred a reassessment of a U.S. primary listing to strengthen its presence in the world’s largest biopharmaceutical market.

10 ARTICLES

last wk.

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

33 ARTICLES

last mo.

NHS Expands Mounjaro Prescriptions to Highest-Risk Patients as Safety Warnings Grow

13 ARTICLES

last mo.

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

3 ARTICLES

last mo.

Eli Lilly’s Oral Pill Matches Injectable GLP-1 Drugs in Phase 3 Diabetes Trials

4 ARTICLES

last mo.

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

8 ARTICLES

last mo.

Mounjaro Delivers Rapid Weight Loss as UK Health Officials Warn of Serious Risks

5 ARTICLES

2mo ago

Oral HIV Drug Lamivudine Improves Vision in Diabetic Macular Edema Trial

8 ARTICLES

2mo ago

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

4 ARTICLES

2mo ago

Novo Nordisk CEO Steps Down Following Market Challenges

5 ARTICLES

2mo ago

Oxford Study Reveals Rapid Weight Regain After Stopping GLP-1 Drugs

5 ARTICLES

2mo ago

Mum Regrets £10k Weight-Loss Surgery After Life-Threatening Complications

3 ARTICLES

2mo ago

WeightWatchers Files for Bankruptcy as GLP-1 Weight-Loss Drugs Reshape Industry

3 ARTICLES

2mo ago

Weight Management Revolution: GLP-1 Drugs Dominate as Pills Emerge

15 ARTICLES

2mo ago

WeightWatchers Files for Chapter 11 Bankruptcy to Restructure $1.15 Billion Debt

40 ARTICLES

2mo ago

WeightWatchers Files for Chapter 11 Bankruptcy to Restructure $1.15 Billion Debt

4 ARTICLES

3mo ago

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

Particle.news

Weight Management

AstraZeneca H1 Revenue Jumps 11% as It Pledges $50 Billion U.S. Expansion

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

NHS Expands Mounjaro Prescriptions to Highest-Risk Patients as Safety Warnings Grow

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

Eli Lilly’s Oral Pill Matches Injectable GLP-1 Drugs in Phase 3 Diabetes Trials

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

NHS Begins Mounjaro Rollout in Primary Care as Regulators Review Safety

Katie Price Sends Son Harvey Back to College After He Smashes £3,000 TV

UK Regulators Warn Weight-Loss Injections Could Undermine Birth Control

Mounjaro Delivers Rapid Weight Loss as UK Health Officials Warn of Serious Risks

Never miss stories about

Weight Management

Oral HIV Drug Lamivudine Improves Vision in Diabetic Macular Edema Trial

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

Novo Nordisk CEO Steps Down Following Market Challenges

Oxford Study Reveals Rapid Weight Regain After Stopping GLP-1 Drugs

Mum Regrets £10k Weight-Loss Surgery After Life-Threatening Complications

WeightWatchers Files for Bankruptcy as GLP-1 Weight-Loss Drugs Reshape Industry

Weight Management Revolution: GLP-1 Drugs Dominate as Pills Emerge

WeightWatchers Files for Chapter 11 Bankruptcy to Restructure $1.15 Billion Debt

WeightWatchers Files for Chapter 11 Bankruptcy to Restructure $1.15 Billion Debt

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

Never miss stories about

Weight Management